Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

13.15USD
19 Dec 2014
Price Change (% chg)

$-0.11 (-0.83%)
Prev Close
$13.26
Open
$13.29
Day's High
$13.38
Day's Low
$13.15
Volume
6,661,296
Avg. Vol
2,906,374
52-wk High
$14.07
52-wk Low
$11.11

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions,... (more)

Overall

Beta: 1.05
Market Cap (Mil.): $17,443.34
Shares Outstanding (Mil.): 1,326.49
Dividend: --
Yield (%): --

Financials

Search Stocks

Transvaginal mesh trial losses put pressure on Boston Scientific

NEW YORK - Boston Scientific Corp’s back-to-back losses in the first two federal trials over its transvaginal mesh devices could drive up the cost of resolving thousands of similar lawsuits, according to legal experts.

22 Nov 2014

Boston Scientific to pay $18.5 million in mesh case

NEW YORK - Boston Scientific Corp was ordered Thursday to pay $18.5 million for injuries caused by transvaginal mesh devices, a plaintiffs’ lawyer said, in the third courtroom loss for the company over the products.

21 Nov 2014

UPDATE 2-Boston Scientific to pay $18.5 mln in mesh case

NEW YORK, Nov 20 - Boston Scientific Corp was ordered Thursday to pay $18.5 million for injuries caused by transvaginal mesh devices, a plaintiffs' lawyer said, in the third courtroom loss for the company over the products.

21 Nov 2014

J&J demands $7.2 billion from Boston Scientific as trial begins

NEW YORK - Boston Scientific Corp should pay Johnson & Johnson $7.23 billion in damages and interest for breach of contract, nearly nine years after Boston Scientific won a controversial bidding war for device maker Guidant, lawyers for J&J told a U.S. federal judge on Thursday.

20 Nov 2014

J&J demands $7.2 bln from Boston Scientific as trial begins

NEW YORK, Nov 20 - Boston Scientific Corp should pay Johnson & Johnson $7.23 billion in damages and interest for breach of contract, nearly nine years after Boston Scientific won a controversial bidding war for device maker Guidant, lawyers for J&J told a U.S. federal judge on Thursday.

20 Nov 2014

Boston Scientific ordered to pay $14.5 mln for transvaginal mesh injuries

NEW YORK, Nov 20 - Boston Scientific Corp was ordered Thursday to pay $14.5 million for injuries caused by transvaginal mesh devices and may face millions of dollars in additional damages, in the third courtroom loss for the company over the devices, a plaintiffs' lawyer said.

20 Nov 2014

Boston Scientific stent succeeds in study aimed at U.S. approval

CHICAGO, Nov 19 - Boston Scientific Corp's next generation Synergy heart stent succeeded in a pivotal study that will be used to seek U.S. and Japanese approval of the device, according to data presented at the American Heart Association meeting in Chicago on Wednesday.

19 Nov 2014

BUSINESS-NEWS-SCHEDULE AT 1630 GMT /11:30 AM ET

(Adds CHICAGO/WASHINGTON story schedule, adds PIX to Keystone story)

19 Nov 2014

BUSINESS-NEWS-SCHEDULE AT 1600 GMT /11:00 AM ET

Could Obama cut deal on Keystone pipeline? Don't rule it out

19 Nov 2014

RPT-J&J seeks over $5 bln in damages from Boston Scientific at trial

NEW YORK, Nov 19 - Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp , Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.

19 Nov 2014

Competitors

  Price Change
Abbott Laboratories (ABT.N) $46.05 +0.28
Medtronic, Inc. (MDT.N) $74.62 -0.01
St. Jude Medical, Inc. (STJ.N) $67.17 -0.06

Earnings vs. Estimates

Search Stocks